Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong
· Delayed Price · Currency is HKD 4.800
-0.080 (-1.64%)
Jun 23, 2025, 4:08 PM HKT
HKG:1167 Revenue
In the year 2024, Jacobio Pharmaceuticals Group had annual revenue of 155.71M CNY with 145.13% growth. Jacobio Pharmaceuticals Group had revenue of 155.71M in the half year ending December 31, 2024, with 279.23% growth.
Revenue
155.71M CNY
Revenue Growth
+145.13%
P/S Ratio
22.85
Revenue / Employee
605.87K CNY
Employees
257
Market Cap
3.79B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| CSPC Pharmaceutical Group | 28.99B |
| Akeso | 2.26B |